These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37915820)

  • 1. Life-time HIV testing among people who inject drugs in Iran: results from the National Rapid Assessment and Response survey.
    Roshanfekr P; Karimi SE; Narouee S; Moftakhar L; Vameghi M; Ali D; Higgs P; Soleimanvandiazar N
    Front Public Health; 2023; 11():1253407. PubMed ID: 37915820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Awareness and willingness to use HIV self-testing among people who inject drugs in Iran.
    Khezri M; Goldmann E; Tavakoli F; Karamouzian M; Shokoohi M; Mehmandoost S; Ghalekhani N; Haghdoost AA; Des Jarlais D; Mirzazadeh A; Sharifi H
    Harm Reduct J; 2023 Oct; 20(1):145. PubMed ID: 37805505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV prevalence among people who inject drugs (PWID) and related factors in Iran: a systematic review, meta-analysis and trend analysis.
    Rahimi J; Gholami J; Amin-Esmaeili M; Fotouhi A; Rafiemanesh H; Shadloo B; Rahimi-Movaghar A
    Addiction; 2020 Apr; 115(4):605-622. PubMed ID: 31631425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low HIV testing rate and its correlates among men who inject drugs in Iran.
    Shokoohi M; Karamouzian M; Osooli M; Sharifi H; Fahimfar N; Haghdoost A; Zamani O; Mirzazadeh A
    Int J Drug Policy; 2016 Jun; 32():64-9. PubMed ID: 27157980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers and motivators to participation and retention in HIV/HCV cohort studies among people who inject drugs: a community consultation in Iran.
    Mirzazadeh A; Hosseini-Hooshyar S; Shahesmaeili A; Bahramnejad A; Barshan A; Mousavian G; Najafi E; Sharifi H; Haghdoost AA; Briceno A; McFarland W; Page K
    Subst Abuse Treat Prev Policy; 2020 Aug; 15(1):56. PubMed ID: 32758246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing risk environments for HIV among people who inject drugs from three cities in Northern Mexico.
    Ospina-Escobar A; Magis-Rodríguez C; Juárez F; Werb D; Bautista Arredondo S; Carreón R; Ramos ME; Strathdee S
    Harm Reduct J; 2018 May; 15(1):27. PubMed ID: 29776368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Willingness to utilize supervised injection facilities among people who inject drugs in Iran: Findings from 2020 national HIV bio-behavioral surveillance survey.
    Khezri M; Karamouzian M; Sharifi H; Ghalekhani N; Tavakoli F; Mehmandoost S; Mehrabi F; Pedarzadeh M; Nejat M; Noroozi A; Baral S; Shokoohi M
    Int J Drug Policy; 2021 Nov; 97():103355. PubMed ID: 34242959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV prevention cascades for injection and sexual risk behaviors among HIV-negative people who inject drug in Iran.
    Gangi MF; Karamouzian M; Nedjat S; Rahimi-Movaghar A; Yazdani K; Shokoohi M; Mirzazadeh A
    Int J Drug Policy; 2020 Oct; 84():102868. PubMed ID: 32717706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Injection drug use practices and HIV infection among people who inject drugs in Kigali, Rwanda: a cross-sectional study.
    Twahirwa Rwema JO; Nizeyimana V; Prata NM; Okonkwo NE; Mazzei AA; Muhirwa S; Rukundo A; Lucas L; Niyigena A; Makuza JD; Beyrer C; Baral SD; Kagaba A
    Harm Reduct J; 2021 Dec; 18(1):130. PubMed ID: 34911554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Access to harm reduction programs among persons who inject drugs: findings from a respondent-driven sampling survey in Tehran, Iran.
    Rahnama R; Mohraz M; Mirzazadeh A; Rutherford G; McFarland W; Akbari G; Malekinejad M
    Int J Drug Policy; 2014 Jul; 25(4):717-23. PubMed ID: 24974367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Public injecting and its association with mental health and other drug-related outcomes among people who inject drugs in Iran.
    Khezri M; Tavakoli F; Karamouzian M; Sharifi H; Ghalehkhani N; Mousavian G; Mehmandoost S; Bazargani M; Hosseinpour AM; Mahboubi M; Baral S; Shokoohi M
    J Subst Abuse Treat; 2022 Dec; 143():108868. PubMed ID: 36137306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Network centrality and HIV prevention service use among people who inject drugs: Findings from a sociometric network cohort in New Delhi, India.
    Prata Menezes N; Mehta SH; Wesolowski A; Clipman SJ; Srikrishnan AK; Kumar MS; Zook KJC; Lucas GM; Latkin C; Solomon SS
    Addiction; 2024 Mar; 119(3):570-581. PubMed ID: 37967827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV Prevalence and Related Behaviors Among People Who Inject Drugs in Iran from 2010 to 2020.
    Khezri M; Shokoohi M; Mirzazadeh A; Tavakoli F; Ghalekhani N; Mousavian G; Mehmandoost S; Kazerooni PA; Haghdoost AA; Karamouzian M; Sharifi H
    AIDS Behav; 2022 Sep; 26(9):2831-2843. PubMed ID: 35195820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid situational assessment of people who inject drugs (PWID) in Nairobi and coastal regions of Kenya: a respondent driven sampling survey.
    Oguya FO; Kenya PR; Ongecha F; Mureithi P; Musyoka H; Muraguri N; Mundia B; Angira C; Shose M; Basheeb TA; Mohamed AA; Oyore JP; Ochieng OG; Dida GO; Abdalla S; Abdool R
    BMC Public Health; 2021 Aug; 21(1):1549. PubMed ID: 34391389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and risk factors for injection site skin infections among people who inject drugs (PWID) in Tehran.
    Noroozi M; Armoon B; Ghisvand H; Noroozi A; Karimy M; Bazrafshan MR; Marshall BDL; Dieji B
    J Cosmet Dermatol; 2019 Feb; 18(1):258-262. PubMed ID: 29781249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Socio-cognitive factors influencing access to HIV prevention services among people who inject drugs in Dar es Salaam, Tanzania: An integrated bio-behavioural survey.
    Likindikoki SL; Meyrowitsch DW; Mizinduko MM; Ishungisa AM; Tersbøl BP; Leyna GH; Moen K; Makyao N; Lange T; Leshabari MT; Mmbaga EJ
    PLoS One; 2022; 17(1):e0261500. PubMed ID: 35089928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and risk factors of HIV infection among people who inject drugs in Cambodia: findings from a national survey.
    Mburu G; Chhoun P; Chann N; Tuot S; Mun P; Yi S
    Subst Abuse Treat Prev Policy; 2019 Oct; 14(1):42. PubMed ID: 31623645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Dual Partnership and Sexual and Injecting Behaviors Among Persons Who Inject Drugs in 23 US Cities, 2018.
    Li X; Sullivan P; Broz D; Handanagic S;
    Arch Sex Behav; 2022 Jul; 51(5):2667-2678. PubMed ID: 35704143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional survey.
    Scheibe A; Young K; Moses L; Basson RL; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Manamela J; Puren AJ; Rebe K; Hausler H
    Harm Reduct J; 2019 Apr; 16(1):28. PubMed ID: 30975139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Needle and Syringe Programs and HIV-Related Risk Behaviors Among Men Who Inject Drugs: A Multilevel Analysis of Two Cities in Iran.
    Noroozi M; Noroozi A; Sharifi H; Harouni GG; Marshall BDL; Ghisvand H; Qorbani M; Armoon B
    Int J Behav Med; 2019 Feb; 26(1):50-58. PubMed ID: 30460445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.